News

AIBN researchers are using the latest sequencing technology developed by UK-based biotech Oxford Nanopore Technologies to analyse mRNA vaccines and therapies.

Hemanshi Galaiya's work in synthetic biology is just part of the wider picture of how she is changing the world.

AIBN researchers are hoping to turn the tide on ocean waste with customised seawater-degradable plastics made using 3D-printing techniques.

The AIBN's Centre for Advanced Imaging (CAI) has launch an Australian-first facility that will use radiometals for cancer therapy.

Two rising research stars have shown just why the AIBN is renowned as an incubator for scientific talent, each securing $440,000 funding to accelerate their game-changing work.

Certain mysteries surrounding the aging process are starting to unravel, thanks to promising work by the AIBN’s Associate Professor Jessica Mar and Professor Ernst Wolvetang.

In the hunt for new and more sophisticated cancer-fighting tools, theranostics are a promising double-act: an emerging group of materials capable of identifying and healing tumours.

At the AIBN, our researchers are pushing the boundaries of personalised medicine: developing new, patient-specific treatments to address serious diseases. But we’ve also got people whose mission is to prevent sickness in the first place.

Sonodynamic therapy is a promising, non-invasive cancer treatment. And now AIBN researchers think they've made the process even more effective.

Our PhD candidates have a laser-sharp focus on industry and translating lab ideas into real-life outcomes. Here are two AIBN scholars who teamed up with industry partners for their research, then landed a job with them.

The winners in this year’s AIBN Image Contest have been unveiled, showing that some of the most spectacular science occurs on the very smallest of scales.

For Professor Yusuke Yamauchi, bucking the trend is essential to the future of clean energy systems.

Yeast has long been a cheap and abundant ingredient in bread and beer and thanks to its unique chemical properties, it can now be used in diagnostic technologies that rival PCR testing for speed and sensitivity.

Two projects led by AIBN researchers – and another that features some of our brightest minds – have been recognised with $2m funding under the latest ARC Linkage Grants round.

Joy Wolfram's mission is to essentially reshape what we know about the medical landscape. Here's how she is positioning Australia as a global leader in extracellular vesicle medicine.

Designing a new biodegradable ‘plastic’ bag could help change the way we farm mushrooms and open lucrative opportunities in packaging and manufacturing.

AIBN researchers have won $500,000 to design an easy-to-use device that can effectively apply their groundbreaking snake venom hydrogel.

A thin, flexible gold sensor engineered at the AIBN has the potential to unlock the next generation of implantable medical devices.

AIBN scientists are working on a cleaner, greener way to keep our planes in the air as we transition to a net-zero world.

What makes a leader? The person with the loudest voice? An unmatched drive to be seen and heard? PhD scholar Nyakuoy Yak says there's no reason it can't be someone sitting quietly behind a microscope.